Scott Max Herbig,Sriram Krishnaswami,Joseph Kushner, IV,Manisha Lamba,Thomas C. Stock
申请号：
US16817689
公开号：
US20200206232A1
申请日:
2020.03.13
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to oral sustained release formulations of tofacitinib and pharmaceutical acceptable salts thereof. The formulations described herein have desirable pharmacokinetic characteristics.
